medetomidine has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, M; Hamamoto, Y; Hasegawa, D; Kuwabara, T; Matsuki, N; Mizoguchi, S; Ogawa, F; Uchida, K | 1 |
| Ajimi, S; Hashizume, N; Imatanaka, N; Kobayashi, T; Nakai, M; Oshima, Y; Tsubokura, Y | 1 |
| Gilsbach, R; Hein, L; Leemhuis, J; Lother, A; Schickinger, S; Schneider, J | 1 |
| Antunes, LM; Olsson, IA; Ribeiro, PO; Rodrigues, P; Valentim, AM | 1 |
| Laengle, UW; Markstein, R; Nogues, V; Provencher-Bollinger, A; Roman, D; Trendelenburg, AU | 1 |
| McPherson, RW; Mirski, MA; Rossell, LA; Traystman, RJ | 1 |
| Halonen, T; Kotti, T; Miettinen, R; Riekkinen, PJ; Toppinen, A; Tuunanen, J | 1 |
| Kim, HK; Maze, M; Strnat, MA; Zornow, MH | 1 |
| MacDonald, E; Rouhiainen, H; Urtti, A; Vartiainen, J; Virtanen, R | 1 |
9 other study(ies) available for medetomidine and Disease Models, Animal
| Article | Year |
|---|---|
Electroencephalographic features of familial spontaneous epileptic cats.
Topics: Animals; Bemegride; Brain; Cats; Convulsants; Disease Models, Animal; Electrodes, Implanted; Electroencephalography; Epilepsy; Epilepsy, Temporal Lobe; Family; Female; Hippocampus; Hypnotics and Sedatives; Male; Medetomidine; Scalp; Seizures; Temporal Lobe; Video Recording | 2014 |
Effects of pentobarbital, isoflurane, or medetomidine-midazolam-butorphanol anesthesia on bronchoalveolar lavage fluid and blood chemistry in rats.
Topics: Administration, Inhalation; Analgesics, Opioid; Anesthesia; Anesthetics, Inhalation; Animals; Biomarkers; Bronchoalveolar Lavage Fluid; Butorphanol; Disease Models, Animal; Hypnotics and Sedatives; Injections, Intraperitoneal; Isoflurane; Lung; Male; Medetomidine; Midazolam; Nickel; Pentobarbital; Pneumonia; Rats, Inbred F344; Risk Assessment | 2016 |
Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Endocytosis; Feedback, Physiological; Fibrosis; Gene Expression Profiling; Heart; Heart Rate; Humans; Hypertension; Medetomidine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocardium; Neurites; Norepinephrine; Promoter Regions, Genetic; Receptors, Adrenergic, alpha-2; RNA, Messenger; Sympathetic Fibers, Postganglionic; Sympathetic Nervous System | 2010 |
Apoptotic neurodegeneration and spatial memory are not affected by sedative and anaesthetics doses of ketamine/medetomidine combinations in adult mice.
Topics: Anesthetics, Combined; Anesthetics, Dissociative; Animals; Apoptosis; Behavior, Animal; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Hemodynamics; Hypnotics and Sedatives; Ketamine; Male; Maze Learning; Medetomidine; Memory Disorders; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; Oxygen | 2012 |
GLC756 decreases TNF-alpha via an alpha2 and beta2 adrenoceptor related mechanism.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Lipopolysaccharides; Medetomidine; Propanolamines; Quinolines; Rats; Rats, Inbred Lew; Receptors, Adrenergic; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-2; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Antagonists; Serotonin Receptor Agonists; Tumor Necrosis Factor-alpha; Uveitis | 2006 |
Dexmedetomidine decreases seizure threshold in a rat model of experimental generalized epilepsy.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Imidazoles; Infusion Pumps; Male; Medetomidine; Motor Activity; Pentylenetetrazole; Rats; Rats, Sprague-Dawley | 1994 |
Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Anticonvulsants; Disease Models, Animal; gamma-Aminobutyric Acid; Hippocampus; Histocytochemistry; Imidazoles; Kainic Acid; Male; Medetomidine; Nerve Degeneration; Neurons; Rats; Rats, Wistar; Seizures; Status Epilepticus; Vigabatrin | 1995 |
Dexmedetomidine does not attenuate increases in excitatory amino acids after transient global ischemia in the rabbit.
Topics: Adrenergic alpha-Agonists; Animals; Disease Models, Animal; Excitatory Amino Acids; Female; Glutamic Acid; Glycine; Hippocampus; Imidazoles; Ischemic Attack, Transient; Male; Medetomidine; Rabbits | 1996 |
Dexmedetomidine-induced ocular hypotension in rabbits with normal or elevated intraocular pressures.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Animals; Disease Models, Animal; Female; Imidazoles; Intraocular Pressure; Lasers; Male; Medetomidine; Ocular Hypertension; Ocular Hypotension; Rabbits | 1992 |